Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Patch

Showing results (31-40 of 115) with videos related to

Pageof 12
Sort By:
Gut|December 20, 2003
Monitoring target reduction in hepatic venous pressure gradient during pharmacological therapy of portal hypertension: a close look at the evidenceU Thalheimer, M Mela, D Patch, et al.
Behaviour Research and Therapy|February 1, 1972
Treatment of heroin addiction with aversion therapy, relaxation training and systematic desensitizationJ S O'Brien, A E Raynes, V D Patch
The International Journal of the Addictions|January 1, 1972
Patterns of drop-outs from a methadone program for natcotic addictsC M Rosenberg, G E Davidson, V D Patch
Cardiovascular and Interventional Radiology|January 24, 2007
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without underlying cirrhosisM Senzolo, D Patch, E Cholongitas, et al.
The New England Journal of Medicine|March 30, 1972
The methadone methodJ S Whyman, G E Woody, V D Patch
Alimentary Pharmacology & Therapeutics|July 25, 2000
Review article: primary prophylaxis for portal hypertensive bleeding in cirrhosisJ Vlachogiannakos, J Goulis, D Patch, et al.
Journal of Hepatology|March 23, 2011
Tips for portal vein thrombosis (pvt) in cirrhosis: not only unblocking a pipeMarco Senzolo, Patrizia Burra, D Patch, et al.
Waste Management (New York, N.Y.)|August 21, 2020
PFOA and PFOS diffusion through LLDPE and LLDPE coextruded with EVOH at 22 °C, 35 °C, and 50 °CV Di Battista, R Kerry Rowe, D Patch, et al.
Gut|July 17, 2001
Angiotensin converting enzyme inhibitors and angiotensin II antagonists as therapy in chronic liver diseaseJ Vlachogiannakos, A K Tang, D Patch, et al.
Alimentary Pharmacology & Therapeutics|May 3, 2000
Review article: pharmacological treatment of the hepatorenal syndrome in cirrhotic patientsL Dagher, D Patch, R Marley, et al.
Pageof 12

Showing results (31-40 of 115) with videos related to

Sort By:
Pageof 12
Gut|December 20, 2003
Monitoring target reduction in hepatic venous pressure gradient during pharmacological therapy of portal hypertension: a close look at the evidenceU Thalheimer, M Mela, D Patch, et al.
Behaviour Research and Therapy|February 1, 1972
Treatment of heroin addiction with aversion therapy, relaxation training and systematic desensitizationJ S O'Brien, A E Raynes, V D Patch
The International Journal of the Addictions|January 1, 1972
Patterns of drop-outs from a methadone program for natcotic addictsC M Rosenberg, G E Davidson, V D Patch
Cardiovascular and Interventional Radiology|January 24, 2007
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without underlying cirrhosisM Senzolo, D Patch, E Cholongitas, et al.
The New England Journal of Medicine|March 30, 1972
The methadone methodJ S Whyman, G E Woody, V D Patch
Alimentary Pharmacology & Therapeutics|July 25, 2000
Review article: primary prophylaxis for portal hypertensive bleeding in cirrhosisJ Vlachogiannakos, J Goulis, D Patch, et al.
Journal of Hepatology|March 23, 2011
Tips for portal vein thrombosis (pvt) in cirrhosis: not only unblocking a pipeMarco Senzolo, Patrizia Burra, D Patch, et al.
Waste Management (New York, N.Y.)|August 21, 2020
PFOA and PFOS diffusion through LLDPE and LLDPE coextruded with EVOH at 22 °C, 35 °C, and 50 °CV Di Battista, R Kerry Rowe, D Patch, et al.
Gut|July 17, 2001
Angiotensin converting enzyme inhibitors and angiotensin II antagonists as therapy in chronic liver diseaseJ Vlachogiannakos, A K Tang, D Patch, et al.
Alimentary Pharmacology & Therapeutics|May 3, 2000
Review article: pharmacological treatment of the hepatorenal syndrome in cirrhotic patientsL Dagher, D Patch, R Marley, et al.
Pageof 12